Single-incision laparoscopic surgery to treat hepatopancreatobiliary cancer: A technical review

World J Gastroenterol. 2022 Jul 21;28(27):3359-3369. doi: 10.3748/wjg.v28.i27.3359.

Abstract

Single-incision laparoscopic surgery (SILS), or laparoendoscopic single-site surgery, was launched to minimize incisional traumatic effects in the 1990s. Minor SILS, such as cholecystectomies, have been gaining in popularity over the past few decades. Its application in complicated hepatopancreatobiliary (HPB) surgeries, however, has made slow progress due to instrumental and technical limitations, costs, and safety concerns. While minimally invasive abdominal surgery is pushing the boundaries, advanced laparoscopic HPB surgeries have been shown to be comparable to open operations in terms of patient and oncologic safety, including hepatectomies, distal pancreatectomies (DP), and pancreaticoduodenectomies (PD). In contrast, advanced SILS for HPB malignancy has only been reported in a few small case series. Most of the procedures involved minor liver resections and DP; major hepatectomies were rarely described. Single-incision laparoscopic PD has not yet been reported. We herein review the published SILS for HPB cancer in the literature and our three-year experience focusing on the technical aspects.

Keywords: Hepatectomy; Hepatopancreatobiliary cancer; Laparoendoscopic single-site surgery; Pancreatectomy; Pancreaticoduodenectomy; Single-incision laparoscopic surgery.

Publication types

  • Review

MeSH terms

  • Hepatectomy / adverse effects
  • Hepatectomy / methods
  • Humans
  • Laparoscopy* / adverse effects
  • Laparoscopy* / methods
  • Minimally Invasive Surgical Procedures
  • Neoplasms*
  • Pancreatectomy / adverse effects
  • Pancreatectomy / methods